Literature DB >> 2457464

Expression and modulation of cell surface determinants on human adult and neonatal monocytes.

P A Marwitz1, E Van Arkel-Vigna, G T Rijkers, B J Zegers.   

Abstract

The difference between newborn and adult mononuclear cells in the antigen dose required for optimal antibody production in vitro can be ascribed to differences in the antigen-presenting capacities of the respective monocytes (Van Tol et al., 1984b). We have therefore studied the expression of cell surface determinants on human neonatal and adult monocytes by the use of monoclonal antibodies to membrane proteins including MHC antigens. No difference was observed in the expression of LeuM3 with regard to both the percentage of positive cells and the density of the respective determinant. In contrast, neonatal cells express the antigens OKM5, LFA1, OKM1 and LeuM5 at a lower density than adult cells do. The same holds for beta 2-microglobulin, but neonatal and adult monocytes express MHC class I alpha-chains at a similar density, whereas among the class II MHC antigens, HLA-DR is significantly more highly expressed on neonatal cells. This difference remains after treatment in vitro with gamma-interferon (gamma-IFN). Treatment with gamma-IFN also resulted in a less dense expression of the LeuM3 antigen. Preincubation of monocytes with LeuM3 monoclonal antibody partially abrogates subsequent upregulation of class II MHC antigens by gamma-IFN, a phenomenon observed with both neonatal and adult monocytes. These data indicate a functional involvement of LeuM3 with the cellular action of gamma-IFN. Taken together, the cell surface phenotype of neonatal monocytes is that of a highly efficient antigen presenting cell.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457464      PMCID: PMC1541519     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Phagocytic cells in cord blood.

Authors:  G Prindull; B Prindull; Z Palti; J M Yoffey
Journal:  Biol Neonate       Date:  1975

2.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

3.  Characterization of ionomycin as a calcium ionophore.

Authors:  C Liu; T E Hermann
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

4.  Antigen-specific plaque-forming cell response of human cord blood lymphocytes after in vitro stimulation by T cell-dependent antigens.

Authors:  M J Van Tol; J Zijlstra; C J Heijnen; W Kuis; B J Zegers; R E Ballieux
Journal:  Eur J Immunol       Date:  1983-05       Impact factor: 5.532

Review 5.  Ontogeny of the immune response as a basis of childhood disease.

Authors:  H F Pabst; H W Kreth
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

6.  Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins.

Authors:  D C Anderson; T A Springer
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

7.  Detection of a novel human class II HLA antigen.

Authors:  A J Watson; R DeMars; I S Trowbridge; F H Bach
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

8.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.

Authors:  A Dimitriu-Bona; G R Burmester; S J Waters; R J Winchester
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

9.  Functional subsets of human monocytes defined by monoclonal antibodies: a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture.

Authors:  H H Shen; M A Talle; G Goldstein; L Chess
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

10.  Macrophage heterogeneity in man. A subpopulation of HLA-DR-bearing macrophages required for antigen-induced T cell activation also contains stimulators for autologous-reactive T cells.

Authors:  H V Raff; L J Picker; J D Stobo
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  6 in total

1.  Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection.

Authors:  F Kanakoudi-Tsakalidou; F Debonera; V Drossou-Agakidou; K Sarafidis; V Tzimouli; A Taparkou; G Kremenopoulos
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.

Authors:  David H Canaday; Soma Chakravarti; Tarun Srivastava; Daniel J Tisch; Vinay K Cheruvu; Jamie Smialek; Clifford V Harding; Lakshmi Ramachandra
Journal:  Cell Immunol       Date:  2007-02-26       Impact factor: 4.868

3.  Differential expression of function-related antigens on newborn and adult monocyte subpopulations.

Authors:  F J Murphy; D J Reen
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  Expression of the CD11/CD18 cell surface adhesion glycoprotein family and MHC class II antigen on blood monocytes and alveolar macrophages in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1992       Impact factor: 2.584

5.  Inhibition of release of arachidonic acid, superoxide, and IL-1 from human monocytes by monoclonal anti-HLA class II antibodies: effects at proximal and distal points of inositol phospholipid hydrolysis pathway.

Authors:  J Puri; M Taplits; M Alava; E Bonvini; T Hoffman
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

6.  Kinetics of human leukocyte antigen receptor HLA-DR+ monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis.

Authors:  Désirée Tampe; Samy Hakroush; Lorenz Biggemann; Martin Sebastian Winkler; Björn Tampe
Journal:  J Nephrol       Date:  2022-04-21       Impact factor: 3.902

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.